Urinary tract infection

Apr 241 min

Cystitis and AMR. A critical analysis in <300 words,

UroPharma produced #intravesical drug-delivery technology to bring, under licence, better cystitis (lower #UTI) treatments. For decades,...

Apr 20, 20231 min

UroPharma is moving rapidly to commercialisation. The science and momentum are with us.

We are now moving into the MANUFACTURING STAGE, going through the pre-launch regulatory processes and distributors have been identified....

Mar 10, 20231 min

New opportunities in bladder treatments.

As part of UroPharma’s development, Urinary Tract Infections are a main focal point. We are please to post our joint collaboration...

Feb 7, 20232 min

New Bladder therapies to ease the suffering of millions by simply changing clinical practice.

UroPharma’s dtb-Instilla Intermittent will: aid the fight against anti-microbial resistance, Urinary Tract Infections and address the...

Nov 25, 20221 min

Benefits of Direct-to-Bladder drug targeting.

Quality of Life is a priority for healthcare professionals. Direct-to-Bladder therapies by UroPharma go a long way towards achieving best...

Aug 12, 20221 min

Direct to Bladder Therapies

About UroPharma UroPharma has patented and developed the world’s first licensed ‘direct to bladder’ drug delivery system, that will be in...